First National Bank & Trust Co. of Newtown Has $742,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

First National Bank & Trust Co. of Newtown decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 2.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,397 shares of the pharmacy operator’s stock after selling 268 shares during the quarter. First National Bank & Trust Co. of Newtown’s holdings in CVS Health were worth $742,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Moneta Group Investment Advisors LLC boosted its position in shares of CVS Health by 103,371.0% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,547,559 shares of the pharmacy operator’s stock valued at $1,448,877,000 after acquiring an additional 15,532,533 shares during the period. Norges Bank bought a new stake in shares of CVS Health in the fourth quarter valued at about $1,425,416,000. FMR LLC boosted its position in shares of CVS Health by 29.1% in the third quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after acquiring an additional 6,194,441 shares during the period. Morgan Stanley boosted its position in shares of CVS Health by 10.9% in the fourth quarter. Morgan Stanley now owns 33,576,388 shares of the pharmacy operator’s stock valued at $3,128,984,000 after acquiring an additional 3,311,928 shares during the period. Finally, Barclays PLC boosted its position in shares of CVS Health by 97.8% in the second quarter. Barclays PLC now owns 5,483,154 shares of the pharmacy operator’s stock valued at $379,052,000 after acquiring an additional 2,711,102 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research report on Wednesday, April 10th. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Barclays assumed coverage on shares of CVS Health in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Royal Bank of Canada cut their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research report on Thursday, February 8th. Finally, HSBC assumed coverage on shares of CVS Health in a research report on Friday, December 22nd. They set a “buy” rating and a $94.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Price Performance

NYSE CVS traded up $0.88 during trading on Friday, hitting $69.61. 3,064,226 shares of the company’s stock were exchanged, compared to its average volume of 10,789,904. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The company has a market cap of $87.74 billion, a PE ratio of 10.75, a P/E/G ratio of 0.91 and a beta of 0.52. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25. The stock’s 50 day moving average price is $75.42 and its two-hundred day moving average price is $73.70.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter in the previous year, the firm earned $1.99 earnings per share. The business’s quarterly revenue was up 11.9% on a year-over-year basis. Research analysts expect that CVS Health Co. will post 8.32 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.82%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

Insider Activity

In other news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.